Targeted Therapies for Non-Small Cell Lung Cancer Underused in Patients on Medicaid
Targeted therapies are underused in Medicaid patients with EGFR- or ALK-altered, metastatic non-small cell lung cancer, research suggests.
Targeted therapies are underused in Medicaid patients with EGFR- or ALK-altered, metastatic non-small cell lung cancer, research suggests.
New research has revealed disparities in access to cancer care among children, adolescents, and young adults in the United States.
The relative risk of treatment delay was about 2 times higher for patients in the highest- vs the lowest-risk region.
Black and Hispanic patients were less likely to receive any opioids compared with White patients.
When accounting for social determinants of health, Black patients have a lower risk of prostate cancer-specific mortality than White patients.
Investigators examined the risk of bone fracture associated with different forms of androgen deprivation therapy.
From 1988 to 2017, there were no significant improvements in breast cancer-specific survival among men in the United States.
Among people with employer-sponsored insurance, women are more likely than men to report being unable to afford needed health care.
Outcomes were worse for Black patients than for White patients, despite similar access to care and socioeconomic status.
Black patients are more likely to undergo emergency surgery for colorectal cancer, which is associated with worse outcomes.